Dudediligence.

Illumina, Inc

ILMNNASDAQ · Laboratory Analytical Instruments
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.08BSep ’24$1.10BDec ’24$1.04BMar ’25$1.06BJun ’25$1.08BSep ’25$1.16BDec ’25$1.09BMar ’26$1.16BJun ’26
Net income, by quarter
$705.0MSep ’24$186.0MDec ’24$131.0MMar ’25$235.0MJun ’25$150.0MSep ’25$334.0MDec ’25$134.0MMar ’26$207.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$4.53B$4.58B$4.50B$4.37B$4.34B
Gross profit$3.15B$2.97B$2.74B$2.86B$2.87B
Operating income−$123.0M−$4.18B−$1.07B−$833.0M$807.0M
Net income$762.0M−$4.40B−$1.16B−$1.22B$850.0M
Operating cash flow$545.0M$392.0M$478.0M$837.0M$1.08B
Free cash flow$337.0M$106.0M$283.0M$709.0M$931.0M
Cash$1.23B$2.01B$1.05B$1.13B$1.42B
Shares outstanding157.0M158.0M159.0M159.0M153.0M